What Alexandria Real Estate Equities Investors Should Keep in Mind

By Emilio Sanchez • Thursday, July 10 15:18 • Permanent Link

Shares of Specialty Real Estate Investment Trust company Alexandria Real Estate Equities jumped 3.3% today. With many investors piling into ARE without a second thought, it may be a good idea to take a closer look at the stock. Here are some quick facts to get you started:

Alexandria Real Estate Equities has moved -38.3% over the last year, and the S&P 500 logged a change of 12.2%
Its trailing earnings per share (EPS) is $0.76
Alexandria Real Estate Equities has a trailing 12 month Price to Earnings (P/E) ratio of 104.8 while the S&P 500 average is 29.3
Its forward earnings per share (EPS) is $3.44 and its forward P/E ratio is 23.1
The company has a Price to Book (P/B) ratio of 0.78 in contrast to the S&P 500's average ratio of 4.74
Alexandria Real Estate Equities is part of the Real Estate sector, which has an average P/E ratio of 27.31 and an average P/B of 1.94
The company has a free cash flow of $1.26 Billion, which refers to the total sum of all its inflows and outflows of cash over the last quarter
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of March 31, 2025, Alexandria has a total market capitalization of $28.8 billion and an asset base in North America that includes 39.6 million RSF of operating properties and 4.0 million RSF of Class A/A+ properties undergoing construction. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in highly dynamic and collaborative Megacampus environments that enhance our tenants' ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.